Altium Capital Management »

ImmunoGen shares owned by Altium Capital Management

Quarter-by-quarter ownership of ImmunoGen shares owned by Altium Capital Management from 13F filings

Historical chart of Altium Capital Management investment in ImmunoGen

Tip: Access up to 7 years of quarterly data

All positions including ImmunoGen held by Altium Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in ImmunoGen by Altium Capital Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $12M 725k 15.87
2023-06-30 $9.2M 485k 18.87
2022-06-30 $1.3M 280k 4.50
2022-03-31 $4.4M 920k 4.76